Full Course Description

Pharmacology of Infectious Diseases & Immunizations

Program Information



Antibacterial Allergies – Sulfa and Penicillin


Antibacterial Resistance–Contributing Factors

Methicillin-Resistant Staphylococcus Aureus - Community versus Hospital Acquired

Enterobacteriaceae Resistance

Urinary Tract Infections

Clostridium Difficile Infection

Community–Acquired Pneumonia

Healthcare–Associated Pneumonia

Upper Respiratory Tract Infections

Skin and Soft Tissue Infections

Strategies to Improve Patient Adherence

Antibacterial Resistance–Prevention Strategies

Emerging and Reemerging Viral Infections


Immunizations (Adult)


  1. Analyze the major classes of antibiotics and their pharmacokinetic characteristics.
  2. Apply current evidenced-based approaches to select appropriate treatment regimens for common infections encountered in clinical practice.
  3. Point out the different types of bacterial etiology and mechanisms of resistance.
  4. Evaluate empiric dosing of antimicrobials.
  5. Communicate important interactions between antimicrobials and other drugs.
  6. Plan goals of therapy and parameters for monitoring therapeutic response to antimicrobials.
  7. Recommend specific antimicrobial therapeutic drug monitoring to maximize efficacy and minimize toxicities (e.g., vancomycin and aminoglycosides).
  8. Develop preventative strategies to limit antimicrobial resistance.
  9. Design patient and caregiver education on the proper use of antimicrobials.
  10. Breakdown local and global ecological factors affecting promotion of viral infection emergence.
  11. Plan for vaccines that are currently recommended for routine administration.

Copyright : 03/15/2016

Cardiac Medications: Management of Complex Cardiovascular Disorders

Program Information


Hemodynamics and Shock

Risk Factor Optimization

Atrial Fibrillation

Therapeutic Advances for Acute Coronary Syndrome

Heart Failure

Pulling it All Together: A Patient-Centered Approach to Pharmacology and Prescribing


  1. Justify the physiological basis for cardiovascular drugs used to support hemodynamics and optimize cardiac output.
  2. Select options in the treatment of dyslipidemia and hypertension by contrasting the differences in lipid lowering agents and comparing the similarities in antihypertensive agents.
  3. Communicate key evidence that guides decision-making regarding pharmacological choices in patients with atrial fibrillation.
  4. Assess the pharmacology in the patient with acute coronary syndrome with short-term and long-term treatment goals.
  5. Determine the role of pharmacological agents in interrupting abnormal neurohormonal responses in patients with heart failure.
  6. Evaluate patient partnering as a method of optimizing medication effectiveness.

Copyright : 03/11/2016